July 30, 2025

Estradiol Worsens Retinal Degeneration in RP

Estradiol increases susceptibility to retinal degeneration in female mice with retinitis pigmentosa, highlighting hormone-specific effects on neurodegenerative disease pathways.

Conexiant

July 30, 2025

August is Children’s Eye Health and Safety Month

Prevent Blindness provides new resources

Optometric Management

July 08, 2025

Management of Complex Dislocated In-the-Bag Intraocular Lenses

Expert vitreoretinal surgeons explain their techniques and strategies in Retinal Physician's new Surgical Pearls video series.

Retinal Physician

August 05, 2025

What Do Patients Look for in Health Care Facilities?

An analysis of online reviews of health care facilities identified language patterns associated with positive or negative patient experiences.

Conexiant

July 23, 2025

Vision Care Organizations Launch Campaign to Defend NEI Amid Federal Funding Threats

A coalition of leading eyecare and research organizations has launched a nationwide campaign to protect the National Eye Institute (NEI) from proposed federal restructuring and funding cuts.

Optometric Management

July 08, 2025

VISTA Trial Completes Enrollment

Topline data from the phase 2/3 trial of gene therapy laru-zova for patients with XLRP are expected next year.

Retinal Physician

July 09, 2025

Medical Oddities: Mondays May Mess With Hormones

Monday cortisol, THC slip-ups, rewiring retinas, tea-buffed muscles, and psyche gyms are what’s the buzz this week!

Conexiant

March 07, 2025

OCT-A Finds Decrease in Retinal Capillary Perfusion in Patients With Long COVID

Retinal structural integrity remained preserved.

Conexiant

April 24, 2025

FDA Rejects Extended Dosing Intervals for Eylea HD

The agency did not agree with Regeneron’s proposal to add dosing intervals greater than every 16 weeks, the maximum interval currently indicated for aflibercept 8 mg injections.

Retinal Physician